1. Home
  2. IMXI vs MRVI Comparison

IMXI vs MRVI Comparison

Compare IMXI & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

N/A

Current Price

$15.79

Market Cap

460.6M

Sector

Technology

ML Signal

N/A

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$3.36

Market Cap

472.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMXI
MRVI
Founded
1994
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
460.6M
472.8M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
IMXI
MRVI
Price
$15.79
$3.36
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$16.67
$4.00
AVG Volume (30 Days)
433.7K
1.2M
Earning Date
01-01-0001
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
1.08
N/A
Revenue
$319,601,000.00
$185,743,000.00
Revenue This Year
$5.86
$11.80
Revenue Next Year
$1.87
$7.74
P/E Ratio
$14.62
N/A
Revenue Growth
16.68
N/A
52 Week Low
$8.58
$1.67
52 Week High
$15.81
$4.11

Technical Indicators

Market Signals
Indicator
IMXI
MRVI
Relative Strength Index (RSI) 65.52 47.24
Support Level $15.42 $3.25
Resistance Level N/A $3.99
Average True Range (ATR) 0.05 0.19
MACD -0.00 0.01
Stochastic Oscillator 82.14 39.11

Price Performance

Historical Comparison
IMXI
MRVI

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: